JPMORGAN CHASE & CO - SOPHIA GENETICS SA ownership

SOPHIA GENETICS SA's ticker is and the CUSIP is H82027105. A total of 33 filers reported holding SOPHIA GENETICS SA in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SOPHIA GENETICS SA
ValueSharesWeighting
Q3 2023$77,829
-51.9%
30,521
-15.5%
0.00%
Q2 2023$161,836
-40.5%
36,124
-34.0%
0.00%
Q1 2023$272,000
+418361.5%
54,728
+74.3%
0.00%
Q4 2022$65
-97.8%
31,392
+3090.2%
0.00%
Q3 2022$3,000
-40.0%
984
+186.9%
0.00%
Q4 2021$5,000
-44.4%
343
-30.4%
0.00%
Q3 2021$9,0004930.00%
Other shareholders
SOPHIA GENETICS SA shareholders Q3 2023
NameSharesValueWeighting ↓
PFM Health Sciences, LP 2,014,024$15,568,0000.58%
GENERATION INVESTMENT MANAGEMENT LLP 6,789,560$52,483,0000.24%
PURA VIDA INVESTMENTS, LLC 829,930$6,415,0000.21%
BANK PICTET & CIE (ASIA) LTD 64,420$498,0000.14%
BANQUE PICTET & CIE SA 2,096,420$16,205,0000.12%
Moloney Securities Asset Management, LLC 71,450$552,0000.11%
GENERAL ELECTRIC CO 1,111,111$8,588,8880.09%
Bank Pictet & Cie (Europe) AG 227,600$1,759,0000.07%
RTW INVESTMENTS, LP 226,589$1,752,0000.04%
DRIEHAUS CAPITAL MANAGEMENT LLC 287,406$2,222,0000.03%
View complete list of SOPHIA GENETICS SA shareholders